D-1350-2014 Class II Terminated

Recalled by Sandoz, Inc — Princeton, NJ

FDA drug recall D-1350-2014 was initiated by Sandoz, Inc on May 22, 2014 and is designated Class II. Reason for recall: Presence of Foreign Substance: Presence of stainless steel particles. The recall status is terminated (terminated Feb 5, 2015). Affected quantity: 22,818 Bottles.

Recall details

Product Type
Drugs
Report Date
Jun 4, 2014
Initiation Date
May 22, 2014
Termination Date
Feb 5, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
22,818 Bottles

Product description

Cefpodoxime Proxetil Tablets, USP, 200 mg, 20 Tablet Bottles, Rx Only. Manufactured in Austria by Sandoz GmbH for Sandoz Inc. Princeton, NJ 08540. NDC 0781-5439-20.

Reason for recall

Presence of Foreign Substance: Presence of stainless steel particles.

Distribution pattern

Nationwide including Puerto Rico.

Code information

Lot #: DZ4056, Expiry: 11/2015; Lot # DZ4057, Expiry: 01/2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1350-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1350-2014. Report a data issue: hello@regdatalab.com.